Lysophospholipid Metabolism and Signalling in Non-Alcoholic Fatty Liver Disease.
Folia Med (Plovdiv)
; 64(1): 7-12, 2022 Feb 28.
Article
en En
| MEDLINE
| ID: mdl-35851901
ABSTRACT
Non-alcoholic liver disease (NAFLD) constitutes a global health pandemic. It is estimated that about 25% of the world's population suffers from NAFLD. In the long-term, a subgroup of the patients can develop inflammation and fibrosis. The end result in some cases is cirrhosis and even liver-related death. The epidemiology and natural history of NAFLD lead to extreme financial costs.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad del Hígado Graso no Alcohólico
Límite:
Humans
Idioma:
En
Revista:
Folia Med (Plovdiv)
Año:
2022
Tipo del documento:
Article
País de afiliación:
Grecia